Explore individual compounds, blends and separate-vial combinations. Compare specifications and follow each item to its reference guide.
The directory lists Cerebrolysin in a 60 mg reference format. The name and unit presentation deserve careful checking against actual product documentation. Listed specification: 60 mg.
Chonluten has a dedicated 20 mg catalog entry. It is kept distinct from Cartalax and other products with the same nominal size. Listed specification: 20 mg.
CJC-1295 DAC is listed separately from the no-DAC form, with 2 mg and 5 mg reference sizes. Listed specification: 2 mg.
CJC-1295 DAC is listed separately from the no-DAC form, with 2 mg and 5 mg reference sizes. Listed specification: 5 mg.
CJC-1295 NO DAC has a standalone 5 mg listing and appears in an independently listed combination with ipamorelin. Listed specification: 5 mg.
Cortagen appears as an individual 20 mg entry within the directory of named research materials. Listed specification: 20 mg.
DSIP is listed in 5 mg and 10 mg formats. The abbreviated name and vial amount are recorded as separate parts of its specification. Listed specification: 10 mg.
DSIP is listed in 5 mg and 10 mg formats. The abbreviated name and vial amount are recorded as separate parts of its specification. Listed specification: 5 mg.
Epitalon and Epithalon are both included in this entry title to make the spelling variants easier to find. Listed specification: 10 mg.
FOXO4-DRI is a dedicated 10 mg catalog reference. The full suffix is retained to distinguish it from broader FOXO4 terminology. Listed specification: 10 mg.
GHK-Cu appears in 50 mg and 100 mg formats. The copper-associated name is preserved throughout the catalog. Listed specification: 50 mg.
GHRP-2 is listed in 5 mg and 10 mg formats, with a separate entry for a CJC-1295/GHRP-2 blend. Listed specification: 10 mg.